Surat-based Anupam Rasayan completes 1,750-cr acquisition of 48.2% in Bliss GVS Pharma
2026-09-29 18:48:09Surat-based Anupam Rasayan completes 1,750-cr acquisition of 48.2% in Bliss GVS Pharma thehindubusinessline.com...
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
06-Oct-2026 | Source : BSEPlease find enclosed herewith the certificate under Regulation 74(5) of SEBI(DP) Regulations 2018 for the quarter ended September 30 2026.
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
06-Oct-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations")
01-Oct-2026 | Source : BSEPlease find enclosed herewith the outcome of the Board Meeting held today i.e. Thursday October 01 2026 through Video Conferencing or Other Audio Visual Means.
Corporate Actions
No Upcoming Board Meetings
Bliss GVS Pharma Ltd has declared 100% dividend, ex-date: 08 Jul 26
Bliss GVS Pharma Ltd has announced 1:10 stock split, ex-date: 11 Mar 08
Bliss GVS Pharma Ltd has announced 3:5 bonus issue, ex-date: 26 Sep 08
No Rights history available